Sha, Cao
Jia, Gao
Jingjing, Zhao
Yapeng, Hu
Zhi, Lou
Guanghui, Xu
Article History
Received: 13 December 2019
Accepted: 28 April 2020
First Online: 29 May 2020
Compliance with ethical standards
:
: All data were generated in-house, and the authors did not use a paper mill.
: The authors declare that they have no competing interests.
: Patients were diagnosed according to the criteria of the World Health Organization classification of hematological malignancies. Before the initiation of treatment, clinical features, including Mantle Cell Lymphoma International Prognostic Index (MIPI) score, lactate dehydrogenase (LDH) content in serum, performance status (determined using Eastern Cooperative Oncology Group performance status scores), and white blood cell (WBC) counts, were collected. All experimental protocols and procedures involved in the present study were approved by the Ethics Committee of the First People’s Hospital of Lianyungang. Written informed consent was obtained from all participants prior to publication of this article.